| Year |
Citation |
Score |
| 2022 |
Wan J, Tanratana P, Roest M, Gruber A, Pawlinski R, Wolberg AS, Mackman N, Grover SP. A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulation. Blood Advances. PMID 36583671 DOI: 10.1182/bloodadvances.2022008720 |
0.328 |
|
| 2021 |
Chang WC, Jackson JW, Machlus KR, Wolberg AS, Ovanesov MV. Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in procoagulant samples. Research and Practice in Thrombosis and Haemostasis. 5: 447-455. PMID 33870030 DOI: 10.1002/rth2.12499 |
0.59 |
|
| 2020 |
Chang WC, Jackson JW, Machlus KR, Wolberg AS, Ovanesov MV. Comparative Analysis of Thrombin Calibration Algorithms and Correction for Thrombin-α2macroglobulin Activity. Journal of Clinical Medicine. 9. PMID 32987791 DOI: 10.3390/jcm9103077 |
0.588 |
|
| 2020 |
Cushman M, Barnes GD, Creager MA, Diaz JA, Henke PK, Machlus KR, Nieman MT, Wolberg AS. Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and Haemostasis. Circulation. 142: e85-e94. PMID 32776842 DOI: 10.1161/Cir.0000000000000818 |
0.624 |
|
| 2020 |
Cushman M, Barnes GD, Creager MA, Diaz JA, Henke PK, Machlus KR, Nieman MT, Wolberg AS. Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis. Research and Practice in Thrombosis and Haemostasis. 4: 714-721. PMID 32685877 DOI: 10.1002/rth2.12373 |
0.592 |
|
| 2020 |
Mackman N, Antoniak S, Wolberg AS, Kasthuri R, Key NS. Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314514. PMID 32657623 DOI: 10.1161/Atvbaha.120.314514 |
0.334 |
|
| 2020 |
Holle LA, Monroe DM, Wolberg AS. VWF (von Willebrand Factor) Is Not Required for Red Blood Cell Retention in Clots in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA120314575. PMID 32580630 DOI: 10.1161/Atvbaha.120.314575 |
0.358 |
|
| 2020 |
Miszta A, Kopec AK, Pant A, Holle L, Byrnes JR, Lawrence DA, Hansen K, Flick MJ, Luyendyk JP, de Laat B, Wolberg AS. High fat diet delays plasmin generation in a thrombomodulin-dependent manner in mice. Blood. PMID 32315384 DOI: 10.1182/Blood.2019004267 |
0.349 |
|
| 2020 |
Tessandier N, Melki I, Cloutier N, Allaeys I, Miszta A, Tan S, Milasan A, Michel S, Benmoussa A, Lévesque T, Côté F, McKenzie SE, Gilbert C, Provost P, Brisson AR, ... Wolberg AS, et al. Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis. Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313698. PMID 32102567 DOI: 10.1161/Atvbaha.119.313698 |
0.354 |
|
| 2020 |
Kattula S, Bagoly Z, Klára Tóth N, Muszbek L, Wolberg AS. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations. Journal of Thrombosis and Haemostasis : Jth. PMID 31989767 DOI: 10.1111/Jth.14744 |
0.361 |
|
| 2020 |
Tang Z, Kattula S, Holle LA, Cooley BC, Lin FC, Wolberg AS. Factor XIII deficiency does not prevent FeCl-induced carotid artery thrombus formation in mice. Research and Practice in Thrombosis and Haemostasis. 4: 111-116. PMID 31989092 DOI: 10.1002/rth2.12278 |
0.308 |
|
| 2020 |
Grover SP, Schmedes CM, Auriemma AC, Butler E, Parrish ML, Miszta A, Cleuren AC, Visser M, Heitmeier S, Posma JJ, Spronk HM, Antoniak S, Wolberg AS, Pawlinski R, Gailani D, et al. Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor. Blood Advances. 4: 207-216. PMID 31935292 DOI: 10.1182/Bloodadvances.2019000921 |
0.369 |
|
| 2019 |
Beckman JD, Wolberg AS. Mechanistic rationale for factor XIII cotreatment in haemophilia. Haemophilia : the Official Journal of the World Federation of Hemophilia. PMID 31577382 DOI: 10.1111/Hae.13855 |
0.307 |
|
| 2019 |
Baker KS, Kopec AK, Pant A, Poole LG, Cline-Fedewa H, Ivkovich D, Olyaee M, Woolbright BL, Miszta A, Jaeschke H, Wolberg AS, Luyendyk JP. Direct Amplification of TF (Tissue Factor). Arteriosclerosis, Thrombosis, and Vascular Biology. ATVBAHA119313215. PMID 31412737 DOI: 10.1161/Atvbaha.119.313215 |
0.377 |
|
| 2019 |
Hofer S, Ay C, Rejtö J, Wolberg AS, Haslacher H, Koder S, Pabinger I, Gebhart J. Thrombin generating potential, plasma clot formation and clot lysis are impaired in patients with bleeding of unknown cause. Journal of Thrombosis and Haemostasis : Jth. PMID 31177606 DOI: 10.1111/Jth.14529 |
0.368 |
|
| 2019 |
Faes C, Ilich A, Sotiaux A, Sparkenbaugh EM, Henderson MW, Buczek L, Beckman JD, Ellsworth P, Noubouossie DF, Bhoopat L, Piegore M, Renoux C, Bergmeier W, Park Y, Ataga KI, ... ... Wolberg AS, et al. Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease. Blood. PMID 30952675 DOI: 10.1182/Blood.2019000424 |
0.416 |
|
| 2019 |
Merkulova AA, Mitchell SC, Merkulov S, Wolberg AS, Marguerite N, Schmaier AH. Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy Blood. 134: 4934-4934. DOI: 10.1182/Blood-2019-131319 |
0.348 |
|
| 2018 |
Hur WS, Mazinani N, Lu XJD, Yefet LS, Byrnes JR, Ho L, Yeon JH, Filipenko S, Wolberg AS, Jefferies WA, Kastrup CJ. Coagulation factor XIIIa crosslinks amyloid b into dimers and oligomers and to blood proteins. The Journal of Biological Chemistry. PMID 30409906 DOI: 10.1074/Jbc.Ra118.005352 |
0.342 |
|
| 2018 |
Durda MA, Wolberg AS, Kerlin BA. State of the art in factor XIII laboratory assessment. Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society For Haemapheresis. PMID 30087086 DOI: 10.1016/J.Transci.2018.07.006 |
0.375 |
|
| 2018 |
Wolberg AS. Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition. Current Opinion in Hematology. PMID 29994896 DOI: 10.1097/Moh.0000000000000445 |
0.311 |
|
| 2018 |
Gidley GN, Holle LA, Burthem J, Bolton-Maggs PHB, Lin FC, Wolberg AS. Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency. Blood Advances. 2: 1076-1088. PMID 29760205 DOI: 10.1182/Bloodadvances.2017015123 |
0.441 |
|
| 2018 |
Wolberg AS. Modeling Venous Thrombosis In Vitro: More Than Just (Valve) Pocket Change. Arteriosclerosis, Thrombosis, and Vascular Biology. 38: 980-981. PMID 29695530 DOI: 10.1161/Atvbaha.118.310919 |
0.379 |
|
| 2018 |
Spronk HMH, Padro T, Siland JE, Prochaska JH, Winters J, van der Wal AC, Posthuma JJ, Lowe G, d'Alessandro E, Wenzel P, Coenen DM, Reitsma PH, Ruf W, van Gorp RH, Koenen RR, ... ... Wolberg AS, et al. Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis. Thrombosis and Haemostasis. 118: 229-250. PMID 29378352 DOI: 10.1160/Th17-07-0492 |
0.438 |
|
| 2018 |
Kattula S, Byrnes JR, Martin SM, Holle LA, Cooley BC, Flick MJ, Wolberg AS. Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice. Blood Advances. 2: 25-35. PMID 29344582 DOI: 10.1182/Bloodadvances.2017011890 |
0.455 |
|
| 2018 |
Telen MJ, Batchvarova M, Beckman JD, Delahunty M, Soldano KL, Ashley-Koch AE, Wolberg AS. Mechanism Underlying a Role for Factor XIII (FXIII) Polymorphism in Sickle Cell Disease-Associated Priapism Blood. 132: 2361-2361. DOI: 10.1182/Blood-2018-99-116946 |
0.381 |
|
| 2017 |
Beckman JD, Holle LA, Wolberg AS. Factor XIII Co-Treatment with Hemostatic Agents in Hemophilia A Increases Fibrin α-Chain Crosslinking. Journal of Thrombosis and Haemostasis : Jth. PMID 29080382 DOI: 10.1111/Jth.13887 |
0.384 |
|
| 2017 |
Byrnes JR, Wolberg AS. Red blood cells in thrombosis. Blood. PMID 28811305 DOI: 10.1182/Blood-2017-03-745349 |
0.365 |
|
| 2017 |
Dargaud Y, Wolberg AS, Gray E, Negrier C, Hemker HC. Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis : Jth. PMID 28656617 DOI: 10.1111/Jth.13743 |
0.325 |
|
| 2017 |
Walton BL, Lehmann M, Skorczewski T, Holle LA, Beckman JD, Cribb JA, Mooberry MJ, Wufsus AR, Cooley BC, Homeister JW, Pawlinski R, Falvo MR, Key NS, Fogelson AL, Neeves KB, ... Wolberg AS, et al. Elevated hematocrit enhances platelet accumulation following vascular injury. Blood. PMID 28251913 DOI: 10.1182/Blood-2016-10-746479 |
0.432 |
|
| 2017 |
Croteau SE, Abajas YL, Wolberg AS, Nielsen BI, Marx GR, Baird CW, Neufeld EJ, Monahan PE. Recombinant porcine factor VIII for high-risk surgery in paediatric congenital haemophilia A with high-titre inhibitor. Haemophilia : the Official Journal of the World Federation of Hemophilia. PMID 28124406 DOI: 10.1111/Hae.13157 |
0.303 |
|
| 2016 |
Byrnes JR, Wolberg AS. New findings on venous thrombogenesis. Hamostaseologie. PMID 27878206 DOI: 10.5482/Hamo-16-09-0034 |
0.382 |
|
| 2016 |
Hisada Y, Geddings JE, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, Bergmeier W, Mackman N. OC-04 - Tissue factor positive microvesicles activate platelets in vitro and in vivo and enhance thrombosis in mice. Thrombosis Research. 140: S169-70. PMID 27161676 DOI: 10.1016/S0049-3848(16)30121-9 |
0.387 |
|
| 2016 |
Byrnes JR, Wolberg AS. Newly-Recognized Roles of Factor XIII in Thrombosis. Seminars in Thrombosis and Hemostasis. PMID 27056150 DOI: 10.1055/S-0036-1571343 |
0.401 |
|
| 2016 |
Unruh D, Ünlü B, Lewis CS, Qi X, Chu Z, Sturm R, Keil R, Ahmad SA, Sovershaev T, Adam M, Van Dreden P, Woodhams BJ, Ramchandani D, Weber GF, Rak JW, ... Wolberg AS, et al. Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma. Oncotarget. PMID 26967388 DOI: 10.18632/Oncotarget.7955 |
0.305 |
|
| 2016 |
Wolberg AS. Primed to Understand Fibrinogen in Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 36: 4-6. PMID 26700134 DOI: 10.1161/Atvbaha.115.306754 |
0.335 |
|
| 2016 |
Beckman JD, Holle LA, Wolberg AS. Co-Administration of Factor XIII with Hemostatic Agents in Hemophilia Promotes Clot Stability and Composition Blood. 128: 2589-2589. DOI: 10.1182/Blood.V128.22.2589.2589 |
0.427 |
|
| 2016 |
Faes C, Ilich A, Sparkenbaugh EM, Wolberg AS, Cooley BC, Ataga KI, Key NS, Pawlinski R. Alteration of the Structure and Dynamics of Venous Clot Formation in Human and Murine Sickle Cell Disease Blood. 128: 2478-2478. DOI: 10.1182/Blood.V128.22.2478.2478 |
0.418 |
|
| 2016 |
Gebhart J, Laczkovics C, Posch F, Ay C, Reitter-Pfoertner SE, Haslacher H, Muszbek L, Wolberg AS, Pabinger I. Plasma clot properties in patients with a mild-to-moderate bleeding tendency of unknown cause Annals of Hematology. 94. DOI: 10.1007/S00277-015-2399-7 |
0.404 |
|
| 2015 |
Geddings JE, Hisada Y, Boulaftali Y, Getz TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, Bergmeier W, Mackman N. Tissue Factor-positive Tumor Microvesicles Activate Platelets and Enhance Thrombosis in Mice. Journal of Thrombosis and Haemostasis : Jth. PMID 26516108 DOI: 10.1111/Jth.13181 |
0.373 |
|
| 2015 |
Amin C, Adam S, Mooberry MJ, Kutlar A, Kutlar F, Esserman D, Brittain JE, Ataga KI, Chang JY, Wolberg AS, Key NS. Coagulation activation in sickle cell trait: an exploratory study. British Journal of Haematology. 171: 638-46. PMID 26511074 DOI: 10.1111/Bjh.13641 |
0.375 |
|
| 2015 |
Hur WS, Mazinani N, Lu XJ, Britton HM, Byrnes JR, Wolberg AS, Kastrup CJ. Coagulation factor XIIIa is inactivated by plasmin. Blood. PMID 26359437 DOI: 10.1182/Blood-2015-07-650713 |
0.422 |
|
| 2015 |
Rautou PE, Tatsumi K, Antoniak S, Owens AP, Sparkenbaugh E, Holle LA, Wolberg AS, Kopec AK, Pawlinski R, Luyendyk JP, Mackman N. Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury. Journal of Hepatology. PMID 26325534 DOI: 10.1016/J.Jhep.2015.08.017 |
0.31 |
|
| 2015 |
Byrnes JR, Duval C, Wang Y, Hansen CE, Ahn B, Mooberry MJ, Clark MA, Johnsen JM, Lord ST, Lam W, Meijers JC, Ni H, Ariëns RA, Wolberg AS. Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking. Blood. PMID 26324704 DOI: 10.1182/Blood-2015-06-652263 |
0.377 |
|
| 2015 |
Krebs CR, Li L, Wolberg AS, Oldenburg AL. A portable blood plasma clot micro-elastometry device based on resonant acoustic spectroscopy. The Review of Scientific Instruments. 86: 075005. PMID 26233406 DOI: 10.1063/1.4926543 |
0.331 |
|
| 2015 |
Aleman MM, Holle LA, Stember KG, Devette CI, Monroe DM, Wolberg AS. Cystamine preparations exhibit anticoagulant activity. Plos One. 10: e0124448. PMID 25915545 DOI: 10.1371/Journal.Pone.0124448 |
0.414 |
|
| 2015 |
Wolberg AS. Factor XIII and Red Blood Cells in Venous Thrombosis Blood. 126: SCI-14-SCI-14. DOI: 10.1182/Blood.V126.23.Sci-14.Sci-14 |
0.441 |
|
| 2015 |
Walton BL, Byrnes JR, Wolberg AS. Fibrinogen, red blood cells, and factor XIII in venous thrombosis Journal of Thrombosis and Haemostasis. 13: S208-S215. DOI: 10.1111/Jth.12918 |
0.372 |
|
| 2014 |
Wang Y, Reheman A, Spring CM, Kalantari J, Marshall AH, Wolberg AS, Gross PL, Weitz JI, Rand ML, Mosher DF, Freedman J, Ni H. Plasma fibronectin supports hemostasis and regulates thrombosis. The Journal of Clinical Investigation. 124: 4281-93. PMID 25180602 DOI: 10.1172/Jci74630 |
0.422 |
|
| 2014 |
Levy JH, Szlam F, Wolberg AS, Winkler A. Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. Clinics in Laboratory Medicine. 34: 453-77. PMID 25168937 DOI: 10.1016/J.Cll.2014.06.005 |
0.337 |
|
| 2014 |
Brummel-Ziedins KE, Wolberg AS. Global assays of hemostasis. Current Opinion in Hematology. 21: 395-403. PMID 25054908 DOI: 10.1097/Moh.0000000000000074 |
0.302 |
|
| 2014 |
Aleman MM, Byrnes JR, Wang JG, Tran R, Lam WA, Paola JD, Mackman N, Degen JL, Flick MJ, Wolberg AS. Factor XIII activity mediates red blood cell retention in venous thrombi Journal of Clinical Investigation. 124: 3590-3600. PMID 24983320 DOI: 10.1172/Jci75386 |
0.377 |
|
| 2014 |
Mitrophanov AY, Wolberg AS, Reifman J. Kinetic model facilitates analysis of fibrin generation and its modulation by clotting factors: implications for hemostasis-enhancing therapies. Molecular Biosystems. 10: 2347-57. PMID 24958246 DOI: 10.1039/C4Mb00263F |
0.429 |
|
| 2014 |
Walton BL, Getz TM, Bergmeier W, Lin FC, Uitte de Willige S, Wolberg AS. The fibrinogen γA/γ′ isoform does not promote acute arterial thrombosis in mice Journal of Thrombosis and Haemostasis. 12: 680-689. PMID 24916154 DOI: 10.1111/Jth.12534 |
0.407 |
|
| 2014 |
Zucker M, Seligsohn U, Salomon O, Wolberg AS. Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency Journal of Thrombosis and Haemostasis. 12: 1121-1130. PMID 24815347 DOI: 10.1111/Jth.12600 |
0.451 |
|
| 2014 |
Aleman MM, Walton BL, Byrnes JR, Wolberg AS. Fibrinogen and red blood cells in venous thrombosis Thrombosis Research. 133: S38-S40. PMID 24759140 DOI: 10.1016/J.Thromres.2014.03.017 |
0.432 |
|
| 2014 |
Wolberg AS. Plasma factor XIII: understanding the 99%. Blood. 123: 1623-4. PMID 24627516 DOI: 10.1182/Blood-2014-01-549683 |
0.325 |
|
| 2014 |
Geddings J, Aleman MM, Wolberg A, von Brühl ML, Massberg S, Mackman N. Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis : Jth. 12: 571-3. PMID 24460606 DOI: 10.1111/Jth.12510 |
0.32 |
|
| 2014 |
Whelihan MF, Lim MY, Walton BL, Wolberg AS, Cai J, Ataga KI, Mann KG, Key NS. Hypercoagulability in Sickle Cell Disease: The Importance of the Cellular Component of Blood Blood. 124: 4060-4060. DOI: 10.1182/Blood.V124.21.4060.4060 |
0.34 |
|
| 2013 |
Aleman MM, Wolberg AS. Tick spit shines a light on the initiation of coagulation. Circulation. 128: 203-5. PMID 23817576 DOI: 10.1161/Circulationaha.113.003800 |
0.305 |
|
| 2013 |
Aleman MM, Walton BL, Byrnes JR, Wang JG, Heisler MJ, Machlus KR, Cooley BC, Wolberg AS. Elevated prothrombin promotes venous, but not arterial, thrombosis in mice Arteriosclerosis, Thrombosis, and Vascular Biology. 33: 1829-1836. PMID 23723374 DOI: 10.1161/Atvbaha.113.301607 |
0.673 |
|
| 2013 |
Wu G, Krebs CR, Lin FC, Wolberg AS, Oldenburg AL. High sensitivity micro-elastometry: applications in blood coagulopathy. Annals of Biomedical Engineering. 41: 2120-9. PMID 23649979 DOI: 10.1007/S10439-013-0817-3 |
0.399 |
|
| 2013 |
Aleman MM, Byrnes JR, Wang J, Mackman N, Degen JL, Flick MJ, Wolberg AS. Fibrin Crosslinking Is Required For Retention Of Red Blood Cells In Venous Thrombi, Blood. 122: 451-451. DOI: 10.1182/Blood.V122.21.451.451 |
0.315 |
|
| 2013 |
Walton BL, Getz TM, Bergmeier W, Uitte de Willige S, Wolberg AS. Gamma Prime Fibrinogen Does Not Cause Arterial Thrombosis Blood. 122: 1092-1092. DOI: 10.1182/Blood.V122.21.1092.1092 |
0.429 |
|
| 2012 |
Dargaud Y, Wolberg AS, Luddington R, Regnault V, Spronk H, Baglin T, Lecompte T, Ten Cate H, Negrier C. Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study. Thrombosis Research. 130: 929-34. PMID 22909826 DOI: 10.1016/J.Thromres.2012.07.017 |
0.324 |
|
| 2012 |
Marchi R, Walton BL, McGary CS, Lin FC, Ma AD, Pawlinski R, MacKman N, Campbell RA, Paola JD, Wolberg AS. Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: Implications for identifying coagulopathic mechanisms in humans Thrombosis and Haemostasis. 108: 516-526. PMID 22836883 DOI: 10.1160/Th12-05-0355 |
0.421 |
|
| 2012 |
Wolberg AS. Determinants of fibrin formation, structure, and function. Current Opinion in Hematology. 19: 349-56. PMID 22759629 DOI: 10.1097/Moh.0B013E32835673C2 |
0.336 |
|
| 2012 |
Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, et al. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood. 119: 5543-52. PMID 22547577 DOI: 10.1182/Blood-2012-01-402156 |
0.341 |
|
| 2012 |
Wolberg AS, Mast AE. Tissue factor and factor VIIa--hemostasis and beyond. Thrombosis Research. 129: S1-4. PMID 22417944 DOI: 10.1016/J.Thromres.2012.02.017 |
0.377 |
|
| 2012 |
Wolberg AS, Aleman MM, Leiderman K, Machlus KR. Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesthesia and Analgesia. 114: 275-85. PMID 22104070 DOI: 10.1213/Ane.0B013E31823A088C |
0.69 |
|
| 2012 |
Hardy E, Sakurai Y, Sanjaya N, Wolberg AS, Lam W. Effect of Locally Applied Electricity On Clot Formation and Hemostasis. Blood. 120: 2220-2220. DOI: 10.1182/Blood.V120.21.2220.2220 |
0.38 |
|
| 2012 |
Ahn B, Sakurai Y, Myers DR, Qiu Y, Hardy E, Tran R, Mannino R, Wolberg AS, Lam W. An “Endothelialized” Microfluidic System That Distinguishes Procoagulant Mechanisms in Arterial and Venous Thrombosis Blood. 120: 1071-1071. DOI: 10.1182/Blood.V120.21.1071.1071 |
0.359 |
|
| 2012 |
Liu X, Mu J, Machlus KR, Wolberg AS, Rosen ED, Xu Z, Alber MS, Chen DZ. Automatic segmentation and analysis of fibrin networks in 3D confocal microscopy images Progress in Biomedical Optics and Imaging - Proceedings of Spie. 8314. DOI: 10.1117/12.911712 |
0.613 |
|
| 2012 |
Wang J, Gambone J, Aleman M, Cardenas J, Chantrathammachart P, Williams J, Kirchhofer D, Bogdanov V, Bach R, Church F, Wolberg A, Pawlinski R, Key N, Yeh J, Mackman N. Human pancreatic cancer cell tissue factor activates coagulation in a mousemodel Thrombosis Research. 129: S171. DOI: 10.1016/S0049-3848(12)70077-4 |
0.3 |
|
| 2011 |
Oldenburg AL, Wu G, Spivak D, Tsui F, Wolberg AS, Fischer TH. Imaging and Elastometry of Blood Clots Using Magnetomotive Optical Coherence Tomography and Labeled Platelets. Ieee Journal of Selected Topics in Quantum Electronics : a Publication of the Ieee Lasers and Electro-Optics Society. 18: 1100-1109. PMID 23833549 DOI: 10.1109/Jstqe.2011.2162580 |
0.34 |
|
| 2011 |
Baglin T, Besser M, Cattaneo M, Dargaud Y, Gray E, Key NS, Lecompte T, Luddington R, Petros S, Siegemund T, Wolberg AS. Towards a recommendation for the standardization of the measurement of platelet-dependent thrombin generation Journal of Thrombosis and Haemostasis. 9: 1859-1861. PMID 21884566 DOI: 10.1111/J.1538-7836.2011.04427.X |
0.336 |
|
| 2011 |
Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. Journal of Thrombosis and Haemostasis : Jth. 9: 2251-61. PMID 21883880 DOI: 10.1111/J.1538-7836.2011.04488.X |
0.384 |
|
| 2011 |
Machlus KR, Lin FC, Wolberg AS. Procoagulant activity induced by vascular injury determines contribution of elevated factor VIII to thrombosis and thrombus stability in mice. Blood. 118: 3960-8. PMID 21828144 DOI: 10.1182/Blood-2011-06-362814 |
0.655 |
|
| 2011 |
Gray LD, Hussey MA, Larson BM, MacHlus KR, Campbell RA, Koch G, Ezban M, Hedner U, Wolberg AS. Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma Thrombosis Research. 128: 570-576. PMID 21561645 DOI: 10.1016/J.Thromres.2011.04.009 |
0.693 |
|
| 2011 |
Machlus KR, Cardenas JC, Church FC, Wolberg AS. Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice. Blood. 117: 4953-63. PMID 21355090 DOI: 10.1182/Blood-2010-11-316885 |
0.69 |
|
| 2011 |
Machlus KR, Aleman MM, Wolberg AS. Update on venous thromboembolism: risk factors, mechanisms, and treatments. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 476-8. PMID 21325668 DOI: 10.1161/Atvbaha.111.223008 |
0.62 |
|
| 2011 |
Bornikova L, Brodsky G, Neeves KB, Marchi R, Backos DS, Reigan P, Wolberg AS, Manco-Johnson MJ, Di Paola JA. A Novel Missense Mutation in FGG (c.944C>A) Encodes for An Amino Acid Change (p.Ala315Asp) in the Gamma Chain of Fibrinogen Causing Hypofibrinogenemia and a Thrombotic Phenotype Blood. 118: 856-856. DOI: 10.1182/Blood.V118.21.856.856 |
0.364 |
|
| 2011 |
Kim E, Kim OV, MacHlus KR, Liu X, Kupaev T, Lioi J, Wolberg AS, Chen DZ, Rosen ED, Xu Z, Alber M. Correlation between fibrin network structure and mechanical properties: An experimental and computational analysis Soft Matter. 7: 4983-4992. DOI: 10.1039/C0Sm01528H |
0.611 |
|
| 2010 |
Wolberg AS. Plasma and cellular contributions to fibrin network formation, structure and stability Haemophilia. 16: 7-12. PMID 20586795 DOI: 10.1111/J.1365-2516.2010.02253.X |
0.38 |
|
| 2010 |
Wolberg AS, Aleman MM. Influence of cellular and plasma procoagulant activity on the fibrin network. Thrombosis Research. 125: S35-7. PMID 20163831 DOI: 10.1016/J.Thromres.2010.01.033 |
0.393 |
|
| 2010 |
Campbell RA, MacHlus KR, Wolberg AS. Editorial: Smoking out the cause of thrombosis Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 7-8. PMID 20018940 DOI: 10.1161/Atvbaha.109.198051 |
0.643 |
|
| 2010 |
Ollivier V, Wang J, Manly D, Machlus KR, Wolberg AS, Jandrot-Perrus M, Mackman N. Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thrombosis Research. 125: 90-6. PMID 19345399 DOI: 10.1016/J.Thromres.2009.03.003 |
0.656 |
|
| 2009 |
Machlus KR, Colby EA, Wu JR, Koch GG, Key NS, Wolberg AS. Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thrombosis and Haemostasis. 102: 936-44. PMID 19888532 DOI: 10.1160/Th09-03-0180 |
0.692 |
|
| 2009 |
Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability Blood. 114: 4886-4896. PMID 19797520 DOI: 10.1182/Blood-2009-06-228940 |
0.352 |
|
| 2009 |
Wolberg AS, Mackman N. Venous thromboembolism: risk factors, biomarkers, and treatment. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 296-7. PMID 19228601 DOI: 10.1161/Atvbaha.109.184580 |
0.328 |
|
| 2008 |
Wolberg AS. Polyphosphate: physiologic? Pathologic? Pharmacologic? Blood. 112: 2598-9. PMID 18809768 DOI: 10.1182/Blood-2008-07-165688 |
0.302 |
|
| 2008 |
Fischer TH, Wolberg AS, Bode AP, Nichols TC. The interaction of factor VIIa with rehydrated, lyophilized platelets. Platelets. 19: 182-91. PMID 18432519 DOI: 10.1080/09537100701493794 |
0.403 |
|
| 2008 |
Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis Transfusion and Apheresis Science. 38: 15-23. PMID 18282807 DOI: 10.1016/J.Transci.2007.12.005 |
0.382 |
|
| 2007 |
Campbell RA, Fischer TH, Wolberg AS. A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation British Journal of Haematology. 138: 82-93. PMID 17555451 DOI: 10.1111/J.1365-2141.2007.06617.X |
0.422 |
|
| 2007 |
Wolberg AS. Antiphospholipid antibody effects on monocytes. Current Rheumatology Reports. 9: 198-204. PMID 17531172 DOI: 10.1007/S11926-007-0032-Z |
0.309 |
|
| 2007 |
Wolberg AS. Thrombin generation and fibrin clot structure. Blood Reviews. 21: 131-42. PMID 17208341 DOI: 10.1016/J.Blre.2006.11.001 |
0.39 |
|
| 2007 |
Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS. A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia Arteriosclerosis, Thrombosis, and Vascular Biology. 27: 683-689. PMID 17204663 DOI: 10.1161/01.Atv.0000257204.82396.2B |
0.391 |
|
| 2006 |
Wolberg AS, Persson E, Hedner U, Ezban M, Allen GA. A Variant of Recombinant Factor VIIa with Enhanced Procoagulant and Antifibrinolytic Activities in a Model of Hemophilia. Blood. 108: 767-767. DOI: 10.1182/Blood.V108.11.767.767 |
0.44 |
|
| 2006 |
Campbell RA, Fischer TH, Wolberg AS. A Novel Use of Rehydrated, Lyophilized Platelets Increases Recombinant FVIIa Procoagulant Activity in a Model of Hemophilia. Blood. 108: 1754-1754. DOI: 10.1182/Blood.V108.11.1754.1754 |
0.412 |
|
| 2005 |
Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. British Journal of Haematology. 131: 645-55. PMID 16351642 DOI: 10.1111/J.1365-2141.2005.05820.X |
0.412 |
|
| 2005 |
Campbell RA, Fischer TH, Wolberg AS. Rehydrated, Lyophilized Platelets Generate Thrombin in the Presence of Recombinant Factor VIIa. Blood. 106: 4057-4057. DOI: 10.1182/Blood.V106.11.4057.4057 |
0.388 |
|
| 2005 |
Wolberg AS, Ezban M, Hedner U, Persson E. Enhanced Fibrin Clot Formation and Stability with a Superactive Analog of Factor VIIa in an In Vitro Model of Hemophilia. Blood. 106: 4056-4056. DOI: 10.1182/Blood.V106.11.4056.4056 |
0.416 |
|
| 2005 |
Fischer TH, Wolberg AS, Bode AP, Ramer KJ, Nichols TC. Interaction of Recombinant Factor VIIa with Rehydrated, Lyophilized Platelets. Blood. 106: 3994-3994. DOI: 10.1182/Blood.V106.11.3994.3994 |
0.351 |
|
| 2004 |
Wolberg AS, Roubey RA. Mechanisms of autoantibody-induced monocyte tissue factor expression. Thrombosis Research. 114: 391-6. PMID 15507269 DOI: 10.1016/J.Thromres.2004.06.012 |
0.36 |
|
| 2004 |
Zhou H, Wolberg AS, Roubey RA. Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. Blood. 104: 2353-8. PMID 15226179 DOI: 10.1182/Blood-2004-01-0145 |
0.343 |
|
| 2004 |
Wolberg AS, Meng ZH, Monroe DM, Hoffman M. A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet function. The Journal of Trauma. 56: 1221-8. PMID 15211129 DOI: 10.1097/01.Ta.0000064328.97941.Fc |
0.346 |
|
| 2003 |
Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood. 101: 3008-13. PMID 12506014 DOI: 10.1182/Blood-2002-08-2527 |
0.382 |
|
| 1997 |
Wolberg AS, Stafford DW, Erie DA. Human factor IX binds to specific sites on the collagenous domain of collagen IV. The Journal of Biological Chemistry. 272: 16717-20. PMID 9201971 DOI: 10.1074/Jbc.272.27.16717 |
0.305 |
|
| 1997 |
Wolberg AS, Morris DP, Stafford DW. Factor IX activation by factor XIa proceeds without release of a free intermediate Biochemistry. 36: 4074-4079. PMID 9100000 DOI: 10.1021/Bi962274Y |
0.324 |
|
| Show low-probability matches. |